| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.03 |